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The U.K. authorities are failing to acknowledge or deal
effectively with an epidemic of work-related cancers.
The government’s Health and Safety Executive (HSE)
underestimates the exposed population, the risks faced
as a result of those exposures, and the potential for pre-
vention. The HSE fails to acknowledge the social
inequality in occupational cancer risk, which is con-
centrated in manual workers and lower employment
grades, or the greater likelihood these groups will
experience multiple exposures to work-related carcino-
gens. It continues to neglect the largely uninvestigated
and unprioritized risk to women and currently has nei-
ther a requirement nor a strategy for reducing the
numbers and volumes of cancer-causing substances,
processes, and environments at work. The result is that
the U.K. faces at least 20,000 and possibly in excess of
40,000 new cases of work-related cancer every year,
leading to thousands of deaths and an annual cost to
the economy of between £29.5bn and £59bn. This
paper  outlines  flaws in the HSE’s approach and makes
recommendations to address effectively the U.K.’s
occupational cancer crisis. Key words: occupational
cancer; Health and Safety Executive; United Kingdom;
public health; policy.
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The U.K. government’s workplace safety agency,the Health and Safety Executive, greatly under-estimates the numbers of workers exposed to
workplace cancer risks and the numbers developing
occupational cancers, and seriously underestimates the
fractions of cancers attributable to occupational expo-
sures when compared with other countries such as
France.1 Although HSE has organized closed seminars
and workshops recently on occupational cancer and is
exploring policy options, it still presents findings of a
1981 US study as “the best overall estimate available.”2
This is the basis of its estimate of just 6,000 occupa-
tional cancer deaths in the United Kingdom each year.
Yet the cost of one occupational cancer death has been
put at £2.46m (US$5million). Even with the HSE esti-
mate of just 6,000 occupational cancer deaths a year,
this amounts to a total annual cost of almost £16bn
(approximately US$30bn). Estimates included in this
paper suggest the real toll and financial cost in Great
Britain could be at least double this.3 Preventing just
100 of these occupational cancer deaths each year
would more than offset the entire HSE annual budget.
The findings of HSE’s preferred source, the 1981
Doll/Peto report,4 have been disputed5 and described
as “discredited,” with authors criticizing both method-
ologic errors that led to a substantial underestimation
of the true incidence6 and the pro-industry leanings of
the lead author.7 Recent analyses suggest the real
number of work-related cancer deaths in Great Britain
each year is at least 12,000 and could be as high as
24,000.8 New figures from the International Labor
Organization support claims that the occupational
cancer rate in developed nations is substantially higher
than HSE’s estimate.9 Basing official policies on
Doll/Peto estimates has resulted in a chronic failure to
secure either the resources or the priority required for
meaningful preventive action. 
Exposure to a workplace cancer risk is not a minor
concern affecting few people. The European Union’s
CAREX database of occupational exposures to carcino-
gens concludes: “According to the preliminary esti-
mates, there were circa 5 million workers (22 per cent of
the employed) exposed to the agents covered by CAREX
in Great Britain in 1990–93. The number of exposures
was circa 7 million.”10 Other recent studies suggest the
number of workers at risk may in fact be increasing. Even
by the CAREX estimate, over a fifth of the U.K. work-
force has been exposed to possible  human carcinogens,
and for these workers most of the resultant cancers will
emerge only after a couple of decades or more. 
Where HSE acknowledges there is a risk, its new esti-
mates of the at-risk working population seem designed
to downplay the problem. In the case of cancer-causing
beryllium, for example, HSE in 2003 said 250 workers
in the United Kingdom were estimated to be continu-
ously exposed and 1,000 workers occasionally exposed
to “very low concentrations of beryllium or beryllium
oxide.” Its 2007 estimate says there are fewer than 1,000
exposed in fewer than 100 workplaces, yet acknowl-
edges that beryllium use is increasing. HSE also ignores
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exposures to beryllium in the scrap-metal and recycling
industries. Even collectors of old radio sets take a more
concerned stance, flagging up risks of beryllium expo-
sures when dismantling radio sets.
HEALTH AND SAFETY OVERSIGHT 
The Health and Safety Executive’s under-resourced
inspectorate is not capable of ensuring adequate safety
oversight of Britain’s workplaces. This was highlighted
by the recent “world’s largest” outbreak of extrinsic aller-
gic alveolitis and occupational asthma, in which over 100
workers at Powertrain in Birmingham developed serious
and chronic occupational lung diseases, despite the risks
having been well established over a decade earlier.11 The
poorly controlled agent responsible, metalworking fluid,
is also an occupational cancer risk.12
Under-reporting of conditions, such as chrome
ulcers, a warning sign of exposures that can lead to
chromium-related lung cancers, indicates HSE’s intelli-
gence on many occupational carcinogen exposures is
lacking. The proliferation of small firms means more
workers are likely now to be working in firms with inad-
equate systems to recognize and deal with risks, and will
remain almost entirely off HSE’s radar. Workplaces reg-
ulated by HSE can expect an inspection only once
every 13 years, or three times in a person’s working life-
time. This is about half the inspection frequency seven
years ago.13 At the same time that the HSE claims to be
making great progress in protecting occupational
health,14 the occupational health staff employed by
HSE has shrunk to such a small number that former
employees seriously doubt whether the group can func-
tion properly at all,15 and its capacity to address the
challenges of occupational cancer looks very restricted.
The HSE initiatives to address occupational cancers
are a small component of an HSE disease-reduction
program, which is a small part of the HSE illness-reduc-
tion program, which is a small part of the HSE Fit3 pro-
gram. This is not enough. HSE plans to inspect only
where there are cancer “exposures.” This assumes
knowledge of where carcinogens are, yet there is no
basis for that assumption within HSE and its inspec-
tions will not normally be sufficient to identify all car-
cinogens, especially if deficient material safety data
sheets are used. In a HSE presentation posted in 2007
on an online HSE silica forum, HSE said findings from
its surveys conducted in 2006 and 2007 in the stone-
masonry, brickmaking, construction, and quarrying
sectors showed it had grossly underestimated the size of
the overexposed population and the levels of crys-
talline silica encountered in the workplace. In stone-
masonry, for example, both HSE and the industry had
estimated no workers were exposed to more than 0.1
mg/m3. In fact, the survey findings suggest 3,150 work-
ers could have been exposed above this level, and 1,425
were potentially exposed to 0.3 mg/m3 or more of res-
pirable crystalline silica. The HSC consultative docu-
ment on the silica standard belatedly resulted in the
U.K. standard's being tightened from 0.3 mg/m3 to 0.1
mg/m3 in 2006—still twice the level recommended by
a European Community panel. Germany now has a
greatly more protective approach to silica risks—they
abandoned a 0.15 mg/m3 standard, and their stan-
dards board, MAK, indicates that an effective standard
should be well below 0.05 mg/m3.
ESTIMATES OF CHEMICAL USE 
Estimates by HSE of those at risk of developing occu-
pational cancers fail to take adequate account of the
rapid increase in the numbers and volumes of sub-
stances used in the workplace. Up to 100,000 chemicals
are in industrial use, an estimated 30,000 used in the
European Union in high volumes (manufactured or
imported in volumes over 1 ton). 
The U.K. Chemical Industries Association in 2006
reported that over the last decade the chemical indus-
try had grown more than five times faster than the aver-
age for all industries. It noted:
the chemical industry accounts for 2 per cent of UK
GDP and 11 per cent of manufacturing industry’s
gross value added. Turnover, which includes the
sales of merchandized goods, e.g., chemicals
imported and then re-sold, was estimated at £50 bil-
lion in 2003. Over the same period sales of domesti-
cally produced chemicals were £34 billion.
The industry’s own figures show that in 2004, while
almost 50% of chemical industry sites had imple-
mented environmental management systems, fewer
than 15% had equivalent health and safety manage-
ment systems.16 The U.K. industry employs directly
about 230,000 workers.
VULNERABLE POPULATIONS
Chemical usage is not just an issue for those in primary
manufacturing or processing. Vulnerable workers, for
example, hairdressers and cleaners, use highly toxic
chemicals routinely and work largely unseen by statu-
tory safety authorities and without occupational health
guidance or access to health and safety expertise. 
When assessing the impact of occupational cancers
on the working population, it is also important to take
into account that almost all the risk is concentrated in a
relatively small segment of the workforce. Work-related
cancer is far more common in blue-collar workers—
there is an undeniable correlation between employ-
ment in lower-status jobs and increased risk.17 Studies
have found, for example, that 40% of the lung and blad-
der cancer cases in certain industrial groups are caused
by occupational exposures.18 French records published
in 2005 found one in eight workers were exposed to
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carcinogens at work, but that the figure was 25% for
manual workers and just 3% for managers.8
The 1998 CAREX report for Great Britain10 con-
cluded that workplace exposures to carcinogens were
restricted to about one fifth of the working population.
If the occupational cancer risk were to be equal across
the population, based on HSE’s figure of 6,000 deaths
a year, this would equate to 1% of all deaths being
caused by occupational cancers in any given year. How-
ever, the responsible exposures are limited to a much
smaller group whose members bear most of the risk,
suggesting that 5% or more of deaths in this group
could be caused by occupational cancers. 
Nor are all the exposed workers in big firms with
occupational health facilities, health and safety profes-
sionals, and sophisticated control systems. Each year
members of the U.K. Chemical Business Association
(CBA) distribute more than 2.5 million tons of chemi-
cals. CBA estimates that small and medium-sized enter-
prises comprise 95% of Europe’s chemical industry. 
Cancers in workers in small firms are unlikely to be
attributed to work unless they are otherwise rare can-
cers, and the workers are unlikely to have access to
informed occupational safety or medical advice.
Research on small firms has shown that they have very
limited understanding of the risks of hazardous sub-
stances and relevant legislation, and that HSE guidance
often does not reach them.19 A 2006 U.K. Federation of
Small Businesses (FSB) report, “Health Matters: A
Small Business Perspective,” reported barely one in 20
survey respondents (6.5%) provided access to occupa-
tional health services. The FSB report concluded small
businesses “need incentives to enable them to promote
healthy workplaces and provide occupational health
support to their staff.”20 So, health and safety manage-
ment in small and medium sized enterprises is still inef-
fective, staffs in local authorities and HSE are insuffi-
cient to check such workplaces, and there is no
possibility that effective cancer-prevention policies and
practices can be introduced under the current system.
COMPLEX EXPOSURES 
The U.K. strategy fails to take adequate account of
complex workplace exposures—multiple exposures at
one time, and multiple changing exposures through a
working lifetime. The use of more substances in higher
volumes in a greatly increased number of products and
processes creates the potential for highly complex
working environments with complex, combined expo-
sures to workplace carcinogens or substances that
could increase vulnerability to carcinogens. A general
dusty environment, for example, can overwhelm the
body’s mucociliary clearance system, allowing easier
passage of airborne substances into the body. Existing
exposure standards and control policies do not reflect
this total carcinogen dose or the complexity of some
mixed workplace exposures, which could create gross
exposures greatly in excess of the exposure limits for
single substances. 
The number of jobs per working lifetime has
increased markedly in the last 30 years, with most work-
ers now having ten or more jobs in the period between
joining the workforce and retirement. New technolo-
gies and processes mean workplace exposures will in
many instances change markedly throughout a working
lifetime.
As Great Britain has no occupational cancer registry
or systematic measures to ascertain or register expo-
sures, HSE does not know who has been exposed, to
what, where, or when. This means only a minority of
cancers—generally otherwise rare and work-specific—
stand any chance of being recognized. This has impli-
cations both for prevention and for workers’ welfare.
Potentially hazardous conditions will not be recognized
or addressed and a victim of occupational cancer is
unlikely to be compensated or to receive a timely diag-
nosis and treatment.
INACTION ON KNOWN RISKS 
Even where the HSE recognizes that a workplace
exposure may cause cancer, this is frequently over-
looked in its practical guidance. HSE’s metalworking
fluid Web pages21 omit any mention of the occupa-
tional cancer risk from the general health risks sec-
tion and guidance for occupational health advisers,
and treat exposure as a general hazard “to be pre-
vented where reasonably practicable” rather than a
cancer hazard where far more stringent stipulations
should apply. Recent evidence suggests there is even
more reason for HSE to issue an explicit cancer warn-
ing. A Harvard University report noted that existing
studies substantially under-estimate the metalworking-
fluids cancer risk.22
When medium-density fiberboard (MDF)—a com-
posite creating potential for exposures to two recog-
nized carcinogens during manufacture or machining—
became the subject of a recent safety controversy, HSE
backed entirely the industry line on potential health
problems, failing to acknowledge the cancer risk.23 It
did not modify this position when formaldehyde was
upgraded in 200424 to the International Agency for
Research on Cancer’s (IARC’s) top cancer-risk cate-
gory, Group 1.25 Wood dust was already rated as an
IARC group 1 carcinogen.
With respect to other substances, HSE has trailed
behind other national regulatory agencies in recogniz-
ing workplace cancer risks, in at least one instance
actively promoting the use of a cancer-causing sub-
stance. In February 2000, the chemical manufacturer
Dow failed in a bid to stop Australia’s chemical stan-
dards body NICNAS from labeling the common indus-
trial solvent trichloroethylene as a carcinogen and
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mutagen. It was two years before HSE issued an equiva-
lent warning. HSE’s 2002 alert said employers should
consider using an alternative solvent or cleaning
process or, if this was not possible, enclosing the
degreasing process as far as possible. Prior to this, HSE
had for a decade—including the two years in which
Australian workers had been warned of the cancer
risks—been explicitly recommending trichloroethyl-
ene use as an “ozone friendly” alternative to the more
worker-friendly trichloroethane. U.K. unions in the
1970s had run successful campaigns to get rid of
trichloroethylene, in some cases negotiating trichloro-
ethane as a safer alternative. Alternative processes,
friendly both to the environment and to the workforce,
had been available when HSE was recommending
trichloroethylene use.
In 1988, NIOSH recommended that perchloro-
ethyelene be labeled a potential occupational carcino-
gen,26 yet into 2000, HSE produced leaflets that did not
mention any cancer link with exposure to this sub-
stance in drycleaning.27
FAILURE TO RECOGNIZE WORK CANCERS 
Many important workplace cancers are entirely over-
looked by HSE. Breast cancers are not treated as a seri-
ous work-related risk to be addressed in HSE’s strategy,
despite evidence that large numbers could be at risk.28
The HSE also misses entire categories of workers
known to have elevated cancer risks. Its list of targeted
work cancer risks does not include “painting.” How-
ever, painters comprise a large occupational group clas-
sified by IARC as facing a Group 1 cancer risk, the top
risk rating.29
Relative to wood dust, another Group 1 IARC car-
cinogen, HSE says this about the cancer risk: “Estab-
lished for cancer of the nasal cavity or sinuses in cabi-
net makers and machinists exposed to wood dust.” In
fact, exposure to wood dust is a nasopharyngeal cancer
and possibly lung cancer risk,30 and has been identified
in almost all woodworking occupations, not just cabinet
making and machining. 
Other occupational groups recognized elsewhere
and in the literature as facing elevated risks for a range
of cancers are also ignored. This includes the increased
risks for non-Hodgkin’s lymphoma and other cancers
in farm workers and a range of cancers in firefighters,
including primary-site brain cancer, primary-site blad-
der cancer, primary-site kidney cancer, primary non-
Hodgkin’s lymphoma, primary-site ureter cancer, pri-
mary-site colorectal cancer, and primary leukemia.8
Firefighters in Canadian provinces such as  Manitoba,
Alberta, Saskatchewan, British Columbia, and Nova
Scotia are already entitled to compensation for work-
related cancers (TUC Risks May 2007; Ontario Ministry
of Labour News release May 4, 2007). No such meas-
ures are on the horizon in the United Kingdom, and
there is little or no evidence that HSE is actively work-
ing to address the risks of this occupational group and
recognize such cancers.
Even for substances such as asbestos, HSE limits its
analysis primarily to the risk of lung cancer and
mesothelioma, despite known associations with many
other cancers. Cancers including gliomas, head and
neck cancers,31 breast and hematopoietic cancers, all
linked to work exposures, are among those largely or
entirely ignored.
OUTDATED AND COMPLACENT DATA 
The Health and Safety Executive is overly reliant on data
from the European Union and IARC. For example, its
briefings on benzene, cadmium, and diesel exhaust are
dangerously outdated, and greatly under-estimate the
potential cancer risks. Nor has HSE practical systems to
review and act on new information in a timely manner,
or to revise assessments.32,33 For instance, Germany and
Denmark recognize bladder cancer in the metal indus-
tries where exposures to cadmium and epoxy resins may
occur. Denmark officially notes the use of azo dyes by
painters: a link not made in the  United Kingdom,
despite recognizing the hazards to printers. The
Sheffield Occupational Health Project (now SOHAS)
identified a series of bladder cancer cases where expo-
sures to cadmium had occurred in situations ranging
from smelters to TV repairs and cutlery work.
On a rare occasion when HSE has revisited occupa-
tional cancer estimates, they have been revised down.
The ratio of asbestos-related lung cancers to mesothe-
liomas is now lower than 1 to 1—a 2005 HSE paper34
puts the ratio of asbestos lung cancers to mesotheliomas
at between 2/3 and 1 to 1—much lower than many
other estimates. The authors acknowledge their figure
will miss some cancers because it underestimates the
effects of chrysotile (white asbestos), which has been
the dominant exposure since 1970. And their analysis
includes cancer deaths up to the age of 74 only, whereas
many asbestos-related lung cancer deaths occur in older
ex- workers. While many observers believe the ratio of
asbestos-related lung cancers to mesothelioma may be
closing as fewer workers are experiencing the very high
exposures that were linked to much higher numbers of
lung cancers, and a drop in smoking will reduce those
caused by the synergy between smoking and asbestos
exposure, HSE’s new estimate is significantly lower than
generally cited figures. 
The data sources used by HSE are also inadequate.
Its chemical-by-chemical approach relies on the limited
work already done. Yet relatively few chemicals in use in
the workplace have been thoroughly assessed for
chronic health risks, fewer still providing sufficient sat-
isfactory data sufficient for listing as a human cancer
risk by either IARC or the European Union. Many
workplaces and substances likely to present substantial
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cancer risks are assumed safe as a result of HSE’s
approach, whereas lack of data means no adequate
assessment of the cancer risk has been undertaken.
This is not a basis for a protective approach, and leaves
workers facing relatively uncontrolled exposures to
substances that may, as data accumulate, be proven to
be cancer-causing. 
FAILURE TO REDUCE RISKS 
The Health and Safety Executive’s approach is entirely
about limited controls on a limited number of carcino-
gens in a limited number of circumstances. It does
nothing to reduce the overall numbers or volumes of
carcinogens at use in workplaces. 
A more responsible approach would be to set targets
for “sunsetting” the most potent carcinogens, and to
introduce a toxics-use-reduction approach to ensure
safer methods and processes are used where they are
effective.35 Toxics use reduction is an approach that not
only has been used effectively, but also has received
strong support from industry.36 Such forward-thinking
strategies are supported elsewhere. The Canadian
Strategy for Cancer Control (CSCC), a coalition of
cancer-prevention, health service, and other bodies,
has taken a public stand in favor of this “primary pre-
vention” of occupational cancer.37
Many researchers have warned that failure to act
promptly on early warnings has in the past led to
entirely avoidable epidemics of occupational diseases,
including workplace asbestos-, benzene-, and radiation-
induced cancers.38
LOW-LEVEL EXPOSURES 
Large groups running small risks from exposures to
workplace carcinogens still amount to a large number
of affected workers, a public health burden entirely
missed by HSE. For example, a report this year identi-
fied a fivefold increase in breast cancer in developed
industrial regions that was in part due to exposure to
industrial chemicals.39
Equally unlikely to be classified as occupational are
the many lung cancers caused by exposures to “nui-
sance” dusts, for example, general building or foundry
dusts. Lung cancer is the standout cancer killer, but is
overwhelmingly attributed to smoking . Latest evidence
suggest that not all these “smoking-related” lung cancer
deaths are actually caused by smoking. As smoking
levels decline in developed nations, a much larger than
expected number of “never-smoked” lung cancers are
being seen. Occupation is a clear contributory factor to
these cancers. 
A Journal of Oncology paper in 2007, for example,
concluded that one in five lung cancers in females and
almost one in ten in men occur in people who have
never smoked.40 That would equate to approaching
3,000 non-smoking lung cancer deaths in U.K. women
each year, and 2,000 deaths in men. Obviously, work-
place exposures would be a co-factor in the lung can-
cers experienced by the smoking group, too—smoking
does not make you immune to occupational lung car-
cinogens. The evidence suggests it does in fact greatly
increase the likelihood of getting a work-related cancer.
EXPOSED WORKERS UNASSISTED 
In the great majority of cases HSE is failing to provide
workers and former workers information about the
cancer risks posed by their past and current exposures
to workplace carcinogens. This has three main detri-
mental effects. 
First, these workers are not in a position to make
informed decisions about their working environments
and seek improvements. Second, they are not in a posi-
tion to seek the health surveillance necessary to
improve the chances of an early cancer diagnosis and
therefore cure. Survival rates in the United Kingdom
for some of the major cancer killers, for example lung
cancer, are low compared with those in other devel-
oped nations. This is in large part due to late diagnosis. 
Finally, lack of awareness and support means most
workers developing occupational cancers receive no
compensation or related benefits, even when work-relat-
edness is extremely well known, as in cases caused by
asbestos exposures. For example, in 2002, 1,862 people
died from the asbestos-induced cancer mesothelioma,
but only 54% of those people received the Industrial
Injuries Disablement Benefit. However, far fewer still
receive this benefit for asbestos-related lung cancer.
Despite its being generally considered that there is at
least one lung cancer death for each mesothelioma
death—and this is a conservative estimate—only 60
lung cancer payments were made in 2001 in the United
Kingdom. Contrast this with Germany, where 767 bene-
fit payments were made for asbestos-related lung cancer
and 665 benefits for mesothelioma in 2001.41 Only some
20 people per year received the Industrial Injuries Dis-
ablement Benefit for occupational bladder cancer,
despite this being a condition which, even by HSE’s con-
servative estimates, affects several hundred workers
every year.
Most occupational cancers occur in older workers, so
there is also a compelling case for health agencies other
than HSE to greatly increase the resources available to
provide advice, screening, and support for retired
workers at risk of developing work-related cancers.
MISTAKES ON SHORT LATENCIES 
The Health and Safety Executive makes the assumption
that occupational cancers have long latency periods,
with today’s cancers the result of exposures a working
generation ago. This has two damaging effects. It allows
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HSE to assume today’s cancers are the result of historic
working conditions, much worse than those in work-
places today. It also allows it to downplay the risks
facing the current working generation. 
For example, relative to wood dust, HSE says: “There
is a latency of 20 years between exposure and tumor
development.” However, many cancers, including those
caused by wood dust, can have much shorter latency
periods. For wood dust, latency can be under ten years.
HSE also says the mode of action is “uncertain.” In fact,
the occupational cancer risk from wood dust results
from inhalation, and is therefore easily preventable.
In Germany and at the Sheffield Occupational Health
Advisory Service  within the United Kingdom, there is a
recognition that minimum latency and exposure times
for occupational cancers may sometimes be much
shorter than the U.K. system recognizes (Table 1).42
LACK OF EMPLOYER KNOWLEDGE 
The Health and Safety Executive makes unprovable
assumptions about improved occupational hygiene
standards and risk reduction, and about the willingness
and capability of firms to recognize and control risks.
HSE’s own studies have shown many chemical compa-
nies had, at least until the mid- to late-1990s, little or no
knowledge of their duties under the chemical-control
regulations, and most were unaware of relevant occupa-
tional exposure limits. At the time, research suggested
many products, including potentially carcinogenic dyes
were being imported without adequate warnings.43
EXPOSURES INSIDE AND OUT OF WORK 
Assumptions about exposure levels and risks based
solely on exposures in the workplace underestimate the
total toxic loads many workers experience. Workers can
be exposed at work and in the general environment.
Women exposed to cancer-causing endocrine-disrupt-
ing chemicals at work, for example, will frequently have
additional exposures to substances acting in the same
way outside work. Again, there is little evidence that
such exposures are yet built into HSE assessments
Likewise, farm workers exposed to pesticides may face
household, environmental and dietary exposures to the
same or related chemicals. A 2007 study found agricul-
tural workers exposed to high levels of pesticides have an
increased risk of brain tumors. All agricultural workers
exposed to pesticides had a slightly elevated brain tumor
risk, but the paper reported the risk was more than dou-
bled for those exposed to the highest levels. The study,
published online in the journal Occupational and Environ-
mental Medicine in May 2007, also found a significant risk
among people who used pesticides on houseplants.44
CHANGING INDUSTRY 
The chemical-by-chemical approach adopted by HSE
fails to take account of the rapid evolution of industry
and industrial processes. Evidence of an emerging
cancer problem in the microelectronics industry45 has
not elicited prompt, precautionary action from HSE, a
failing that has attracted international criticism.46 Simi-
larly, while HSE at least theoretically advocates a pre-
cautionary approach in the fast-emerging nanotechnol-
ogy industry, in practice there is little understanding of
the hazards posed or how they might be controlled.
The industry, meanwhile, largely free from the atten-
tion of the resource-depleted enforcement agency, is
growing at a startling pace.47
The problem is not limited to those employed in
new industries, but also afflicts the much greater
number affected by the changing natures of existing
jobs or job functions. More workers performing rou-
tine tasks are exposed to chemicals as a result of the
tendency to opt for quick chemical fixes applied by
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TABLE 1 Minimal Latencies for Occupational Cancers in the German Compensation System*
Minimum Exposure Minimum
Time Latency
Agent Site (Years) (Years)
Chromium Lung, nasal, upper respiratory tract 2 4
Arsenic Lung, nasal, upper respiratory tract 0.5 3
Aromatic amines Bladder, urinary tract 0.25 1
Halogenated hydrocarbons (VCM, etc.) Liver, bladder, urinary tract 5 11
Benzene, benzene homologs, styrene Leukemia 0.5 2
Halogenated alkyl, aryl or alkyl aryl oxides Lung, urinary tract, skin, nasal, larynx, 2 8
stomach, etc.
Ionizing radiation Lung, leukemia, skin, mesothelioma <1 10
Asbestos Lung <0.25 8
Asbestos Mesothelioma 1 day 15
Nickel Lung, nasal, upper respiratory tract 1 6
Wood dust Nasal adenocarcinoma 5 8
Soot, crude paraffin, tar, anthracene, Skin cancer 3 4
pitch, and related compounds
*Source: Popp et al.42
poorly skilled workers as an alternative to labor- and
resource-intensive skilled labor. For example, many
municipal authorities are opting to use pesticides for
routine weed control as an alternative to employing
skilled parks and garden staff.
CHANGING WORK PATTERNS
Over three million workers in the United Kingdom
work in excess of 48 hours per week, with the potential
for work-time exposures considerably in excess of those
assumed under existing occupational exposure limits,
based on the standard working week. 
In addition, new age-discrimination regulations and
government moves to raise the retirement age mean
many workers are likely to have more years of exposures
to potential risks. The United Kingdom already has one
of Europe’s highest proportions of older workers in
work.48 The changing nature of employment—long
hours, frequent changes of job, frequent changes of job
task, irregular hours, and shift work all impact occupa-
tional cancer risks. Breast and other cancers have been
linked to shift work, something that HSE staff are aware
of, but, to date, no significant relevant policies or practice
recommendations have emerged from the organization.
RISKS TO WOMEN 
Women are now better represented in the workforce,
are likely to spend longer in the workforce, and do a
much wider range of jobs. Since 1975 men’s employ-
ment has declined from around nine of ten to eight of
ten (79%) for men of working age (16–64). At the
same time women’s employment has increased from
around six of ten to seven of ten (70%) for women of
working age (16–59). 
The  approach taken by HSE fails to take adequate
account of the increasing participation of women in the
labor market, or of the risks to women, or of risks in
women-dominated employment areas. For example,
HSE’s estimates of risks in the health sector include far
fewer jobs, cancers, and exposures than the equivalent
guidance from the U.S. National Institute for Occupa-
tional Safety and Health. HSE cannot present any cred-
ible assessment of the occupational cancer risks faced by
women, or the numbers of cancers in women related to
workplace exposures. For example, breast cancer is the
most common cancer in the United Kingdom and one
of the top cancer killers. However, it does not appear on
HSE’s priority action list or in its estimates of the num-
bers affected by occupational cancers, despite clear evi-
dence associating industrial exposures with elevated
cancer risk. An October 2005 report, “Breast Cancer—
An Environmental Disease: The Case for Primary Pre-
vention,” concluded there was “incontrovertible evi-
dence” that many industrial chemicals and radiation are
major contributors to overall breast cancer rates.28
WORK AND LIFESTYLE INTERACTIONS 
The U.K. approach to occupational cancers fails to take
account of the workplace contributions to supposedly
“lifestyle” cancers. For example, work stress is associ-
ated with poor behavior patterns, including smoking
and other substance-abuse behaviors.49
Workplace exposures can also “potentiate” the effect
of tobacco smoke. For example, the synergy between
asbestos exposure and tobacco smoke is well reported,
the combination creating a massively increased risk com-
pared with exposure to either carcinogen alone. And a
2005 paper concluded exposure to wood dust increased
the chances of developing not only nasal cancer but also
lung cancer, finding the risk of lung cancer was
increased by 57% with wood dust exposure in the
absence of smoking, by 71% for smoking in the absence
of wood dust exposure, and by 187% for individuals who
were exposed to both smoking and wood dust.30
PARENTAL EXPOSURES AND CHILDREN 
The impact of work exposures can also be intergenera-
tional, with the impact of work on workers’ children
wholly ignored in HSE’s analysis. For example, a 2003
University of Massachusetts Lowell report noted “evi-
dence increasingly indicates that parental and child-
hood exposures to certain toxic chemicals including
solvents, pesticides, petrochemicals and certain indus-
trial by-products (dioxins and polycyclic aromatic
hydrocarbons) can result in childhood cancer.”50
Recent research has reinforced this evidence.51
And paraoccupational cancers—cancers in those
incidentally exposed to carcinogens via exposures to
asbestos on the clothing of parents or spouses, for
example—are being seen with increasing frequency.52
FUTURE PROBLEM 
The increase in overall life expectancy and declining
death rates from other causes, means for the current
working generation cancer will have longer to develop
and less competition as a cause of death. And while
mortality from cancer is falling as a result of improved
diagnosis and treatment, the incidence of cancer is not,
supporting the case for greater preventive efforts.
KEY RECOMMENDATIONS
• Occupational cancer prevention should be recog-
nized by the government as a major public health pri-
ority and should be allocated resources accordingly.
• A national occupational cancer and carcinogens
awareness campaign should be launched as a matter
of urgency.
• The Health and Safety Executive should convene a tri-
partite working party, including representatives of
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unions, health and safety campaign organizations, and
occupational disease victims’ and advocacy organiza-
tions, to review its occupational cancer strategy.
• Wherever possible, IARC Group 1 and Group 2A
carcinogens should be targeted for “sunsetting,” a
phase-out within a designated time frame, to be
replaced by safer alternatives.
• Toxics use reduction legislation, already used suc-
cessful in some U.S. jurisdictions, should be intro-
duced to encourage the use of the safest suitable
substances and processes. The precautionary princi-
ple should be applied to substances suspected of
causing cancer in humans.
• A national system of occupational health records
should be developed to ensure adequate recording
of workplace exposures and other occupational
cancer risk factors. Employers must have a duty to
inform any workers of their exposures to known or
suspected workplace cancer risks and carcinogens.
• A national exposure database should be created.
• The Health and Safety Executive should provide
resources for training of union safety reps in “lay
epidemioloy”, techniques for the early recognition of
work-related diseases, including cancer, and training
in lay exposure-reporting systems, because trade
union reps, lawyers, and individual workers will be
critical to finding carcinogens and, through REACH-
type mechanisms, feeding back information to other
users, suppliers, and HSE on their locations.
• The United Kingdom should implement properly
the European Union law requiring workers to have
access to occupational health services.
• The government Industrial Injuries Benefit Scheme
should be revised and extended to include a wider
range of occupational cancers in its scope. There
should be a consideration of the introduction of a
“rebuttal presumption” of work causation for can-
cers with established associations with work. Com-
pensation should also ensure that those exposed to
carcinogens are covered. Exposures, not specific
and narrow occupational categories, should deter-
mine compensation.
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